Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2).

Qadri I, Hu LJ, Iwahashi M, Al-Zuabi S, Quattrochi LC, Simon FR.

Toxicol Appl Pharmacol. 2009 Feb 1;234(3):281-92. doi: 10.1016/j.taap.2008.10.005. Epub 2008 Oct 29.

PMID:
19010343
2.

A dioxin-responsive enhancer 3' of the human CYP1A2 gene.

Okino ST, Quattrochi LC, Pookot D, Iwahashi M, Dahiya R.

Mol Pharmacol. 2007 Dec;72(6):1457-65. Epub 2007 Sep 4.

PMID:
17785579
3.

Identification of genes controlled by the pregnane X receptor by microarray analysis of mRNAs from pregnenolone 16alpha-carbonitrile-treated rats.

Guzelian J, Barwick JL, Hunter L, Phang TL, Quattrochi LC, Guzelian PS.

Toxicol Sci. 2006 Dec;94(2):379-87. Epub 2006 Sep 22.

4.
5.

Characterization of adjacent E-box and nuclear factor 1-like DNA binding sequence in the human CYP1A2 promoter.

Narvaez MJ, Anderson GR, Pickwell GV, Quattrochi LC.

J Biochem Mol Toxicol. 2005;19(2):78-86.

PMID:
15849719
7.

A combination of tea (Camellia senensis) catechins is required for optimal inhibition of induced CYP1A expression by green tea extract.

Williams SN, Pickwell GV, Quattrochi LC.

J Agric Food Chem. 2003 Oct 22;51(22):6627-34.

PMID:
14558788
10.

The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human cyp1a1 expression.

Allen SW, Mueller L, Williams SN, Quattrochi LC, Raucy J.

Drug Metab Dispos. 2001 Aug;29(8):1074-9.

PMID:
11454723
11.

Cyp3A regulation: from pharmacology to nuclear receptors.

Quattrochi LC, Guzelian PS.

Drug Metab Dispos. 2001 May;29(5):615-22. Review.

PMID:
11302925
12.

Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin.

Valerio LG Jr, Kepa JK, Pickwell GV, Quattrochi LC.

Toxicol Lett. 2001 Feb 3;119(1):49-57.

PMID:
11275421
13.

Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance.

Aitchison KJ, Gonzalez FJ, Quattrochi LC, Sapone A, Zhao JH, Zaher H, Elizondo G, Bryant C, Munro J, Collier DA, Makoffa AI, Kerwin RW.

Pharmacogenetics. 2000 Nov;10(8):695-704.

PMID:
11186132
14.

Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression.

Williams SN, Shih H, Guenette DK, Brackney W, Denison MS, Pickwell GV, Quattrochi LC.

Chem Biol Interact. 2000 Nov 1;128(3):211-29.

PMID:
11064004
15.
16.

Differential effects of flavonoid compounds on tumor promoter-induced activation of the human CYP1A2 enhancer.

Shih H, Pickwell GV, Quattrochi LC.

Arch Biochem Biophys. 2000 Jan 1;373(1):287-94.

PMID:
10620351
17.

Species differences in hepatocyte induction of CYP1A1 and CYP1A2 by omeprazole.

Shih H, Pickwell GV, Guenette DK, Bilir B, Quattrochi LC.

Hum Exp Toxicol. 1999 Feb;18(2):95-105.

PMID:
10100022
18.

Induction of the human CYP1A2 enhancer by phorbol ester.

Quattrochi LC, Shih H, Pickwell GV.

Arch Biochem Biophys. 1998 Feb 1;350(1):41-8.

PMID:
9466818
19.

Characterization of DNA-binding proteins required for glucocorticoid induction of CYP3A23.

Quattrochi LC, Yockey CB, Barwick JL, Guzelian PS.

Arch Biochem Biophys. 1998 Jan 15;349(2):251-60.

PMID:
9448712
20.
22.

Critical role of extracellular matrix on induction by phenobarbital of cytochrome P450 2B1/2 in primary cultures of adult rat hepatocytes.

Brown SE, Guzelian CP, Schuetz E, Quattrochi LC, Kleinman HK, Guzelian PS.

Lab Invest. 1995 Dec;73(6):818-27.

PMID:
8558843
23.

A novel cis-acting element in a liver cytochrome P450 3A gene confers synergistic induction by glucocorticoids plus antiglucocorticoids.

Quattrochi LC, Mills AS, Barwick JL, Yockey CB, Guzelian PS.

J Biol Chem. 1995 Dec 1;270(48):28917-23.

25.

Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.

Tassaneeyakul W, Birkett DJ, Veronese ME, McManus ME, Tukey RH, Quattrochi LC, Gelboin HV, Miners JO.

J Pharmacol Exp Ther. 1993 Apr;265(1):401-7.

PMID:
8474022
26.
27.

Response of human CYP1-luciferase plasmids to 2,3,7,8-tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydrocarbons.

Postlind H, Vu TP, Tukey RH, Quattrochi LC.

Toxicol Appl Pharmacol. 1993 Feb;118(2):255-62.

PMID:
8442004
28.

Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques.

Tassaneeyakul W, Mohamed Z, Birkett DJ, McManus ME, Veronese ME, Tukey RH, Quattrochi LC, Gonzalez FJ, Miners JO.

Pharmacogenetics. 1992 Aug;2(4):173-83.

PMID:
1306118
29.

High-level expression of functional human cytochrome P450 1A2 in Escherichia coli.

Fisher CW, Caudle DL, Martin-Wixtrom C, Quattrochi LC, Tukey RH, Waterman MR, Estabrook RW.

FASEB J. 1992 Jan 6;6(2):759-64.

PMID:
1537466
30.

Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridization.

McKinnon RA, Hall PD, Quattrochi LC, Tukey RH, McManus ME.

Hepatology. 1991 Nov;14(5):848-56.

PMID:
1657755
31.

Identification of cytochrome P450IA2 as a human autoantigen.

Manns MP, Griffin KJ, Quattrochi LC, Sacher M, Thaler H, Tukey RH, Johnson EF.

Arch Biochem Biophys. 1990 Jul;280(1):229-32.

PMID:
2353823
32.

Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450.

McManus ME, Burgess WM, Veronese ME, Huggett A, Quattrochi LC, Tukey RH.

Cancer Res. 1990 Jun 1;50(11):3367-76.

33.

Metabolism of food derived mutagens and 2-acetylaminofluorene by purified rabbit and cDNA expressed human cytochromes P450.

McManus ME, Burgess WM, Veronese ME, Felton JS, Knize MG, Snyderwine EG, Quattrochi LC, Tukey RH.

Prog Clin Biol Res. 1990;340E:139-47. No abstract available.

PMID:
2392457
34.
35.

Characterization of multiple human cytochrome P-450 1 cDNAs. The chromosomal localization of the gene and evidence for alternate RNA splicing.

Okino ST, Quattrochi LC, Pendurthi UR, McBride OW, Tukey RH.

J Biol Chem. 1987 Nov 25;262(33):16072-9. Erratum in: J Biol Chem 1988 Feb 15;263(5):2576.

36.

Human cytochrome P-450 4 mRNA and gene: part of a multigene family that contains Alu sequences in its mRNA.

Quattrochi LC, Pendurthi UR, Okino ST, Potenza C, Tukey RH.

Proc Natl Acad Sci U S A. 1986 Sep;83(18):6731-5.

37.
38.

Cloning and characterization of cDNAs encoding 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible rabbit mRNAs for cytochrome P-450 isozymes 4 and 6.

Okino ST, Quattrochi LC, Barnes HJ, Osanto S, Griffin KJ, Johnson EF, Tukey RH.

Proc Natl Acad Sci U S A. 1985 Aug;82(16):5310-4.

39.

Microsomal cytochromes P-450 from marine crabs.

Quattrochi LC, Lee RF.

Comp Biochem Physiol C. 1984;79(1):171-6.

PMID:
6149863
40.

alpha-Ketoisocaproate stimulates malate-dependent pyruvate formation in rat heart mitochondria.

Quattrochi LC, Hall LM, Becker GL.

Biochem Biophys Res Commun. 1982 Dec 15;109(3):950-7. No abstract available.

PMID:
7159451

Supplemental Content

Loading ...
Support Center